The World Health Organisation (WHO) has insisted that the Mpox epidemic remains a public health emergency.
WHO first declared an emergency when a new strain of mpox spread from the severely affected Democratic Republic of the Congo to neighbouring countries in August.
The WHO Director-General has decided that the increase in mpox still qualifies as a public health emergency of worldwide significance after the WHO called a meeting of its Emergency Committee and followed its recommendations.
According to WHO, the decision was made in light of the growing number and ongoing geographic dispersion of cases, field operating difficulties, and the requirement to establish and maintain a coordinated response across nations and partners.
Mpox is a virus that is spread by close contact and usually manifests as pus-filled lesions and flu-like symptoms. Although it is typically minor, it can be fatal.
More than 1,000 suspected deaths and more than 46,000 suspected cases have been reported this year throughout Africa, primarily in Congo.
The WHO’s highest level of warning, known as a “public health emergency of international concern,” was previously used to describe a worldwide epidemic of a different type of mpox in 2022–2023.
This year’s notice was issued in response to the transmission of a novel viral variation known as clade Ib. Among other nations, cases of this variation have been verified in the UK, Germany, Sweden, and India.
Following criticism for moving too slowly on vaccinations, WHO approved Bavarian Nordic’s mpox vaccine in September and listed Japan’s KM Biologics vaccine for emergency use earlier this month.